These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2483762)

  • 1. Methylprednisolone affects inhibitors of the complement and the contact systems; functional and immunochemical studies on alpha 2-macroglobulin and C1 inhibitor.
    Roeise O; Stadaas JO; Aasen AO
    Thromb Res; 1989 Dec; 56(6):697-708. PubMed ID: 2483762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose dependence of endotoxin-induced activation of the plasma contact system: an in vitro study.
    Roeise O; Bouma BN; Stadaas JO; Aasen AO
    Circ Shock; 1988 Dec; 26(4):419-30. PubMed ID: 2463883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylprednisolone induces activation of the contact system in a dose-dependent manner. An in vitro study.
    Roeise O; Nuijens JH; Hack CE; Bouma BN; Stadaas JO; Aasen AO
    Thromb Res; 1990 Mar; 57(6):877-88. PubMed ID: 2382256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylprednisolone in high doses gives different effects on the early and the late part of complement.
    Roeise O; Garred P; Mollnes TE; Stadaas JO; Aasen AO
    Eur Surg Res; 1990; 22(1):41-9. PubMed ID: 2199200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The regulation of human factor XIIa by plasma proteinase inhibitors.
    Pixley RA; Schapira M; Colman RW
    J Biol Chem; 1985 Feb; 260(3):1723-9. PubMed ID: 2578463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the dose dependence of endotoxin-induced in vitro activation of the complement system.
    Roeise O; Garred P; Mollnes TE; Aasen AO
    Eur Surg Res; 1989; 21(1):34-41. PubMed ID: 2714308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of kallikrein in human plasma.
    van der Graaf F; Koedam JA; Bouma BN
    J Clin Invest; 1983 Jan; 71(1):149-58. PubMed ID: 6184384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C1 inhibitor function using contact-phase proteases as target: evaluation of an innovative assay.
    Ghannam A; Sellier P; Defendi F; Favier B; Charignon D; López-Lera A; López-Trascasa M; Ponard D; Drouet C
    Allergy; 2015 Sep; 70(9):1103-11. PubMed ID: 26010015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computerized immunoblot analyses (CIBA) of the distribution of prekallikrein and its activation products in vivo and in vitro.
    Veloso D; Campbell G
    Agents Actions Suppl; 1992; 38 ( Pt 1)():166-73. PubMed ID: 1281607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inhibition of Cls activity by methylprednisolone].
    Deguchi M; Takemura S; Ueda M; Ashihara K; Ichio N; Doi T; Nakahara R; Kasamatsu Y; Okamoto M; Fukuda W
    Arerugi; 1992 Sep; 41(9):1398-404. PubMed ID: 1444833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement regulatory protein C1 inhibitor binds to selectins and interferes with endothelial-leukocyte adhesion.
    Cai S; Davis AE
    J Immunol; 2003 Nov; 171(9):4786-91. PubMed ID: 14568956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. alpha2-macroglobulin and C1-inactivator are plasma inhibitors of human glandular kallikrein.
    Heeb MJ; España F
    Blood Cells Mol Dis; 1998 Dec; 24(4):412-9. PubMed ID: 9851894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C1 inhibitor prevents endotoxin shock via a direct interaction with lipopolysaccharide.
    Liu D; Cai S; Gu X; Scafidi J; Wu X; Davis AE
    J Immunol; 2003 Sep; 171(5):2594-601. PubMed ID: 12928411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human monocytes release plasma serine protease inhibitors in vitro.
    Kłoczko J; Bielawiec M; Giedrojć J; Radziwon P; Galar M
    Haemostasis; 1990; 20(4):229-32. PubMed ID: 1700759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-gamma is a major regulator of C1-inhibitor synthesis by human blood monocytes.
    Lotz M; Zuraw BL
    J Immunol; 1987 Nov; 139(10):3382-7. PubMed ID: 3119706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C1-esterase inhibitor in early septicemia.
    Siebeck M; Philapitsch A; Wiesinger H; Welter HF
    Prog Clin Biol Res; 1987; 236A():141-7. PubMed ID: 2441404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on components of the contact phase system in patients with advanced gastrointestinal cancer.
    Roeise O; Sivertsen S; Ruud TE; Bouma BN; Stadaas JO; Aasen AO
    Cancer; 1990 Mar; 65(6):1355-9. PubMed ID: 1689607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-linked glycosylation is required for c1 inhibitor-mediated protection from endotoxin shock in mice.
    Liu D; Gu X; Scafidi J; Davis AE
    Infect Immun; 2004 Apr; 72(4):1946-55. PubMed ID: 15039314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cold promoted activation and factor XII, prekallikrein and C1-inhibitor.
    Czendlik C; Lämmle B; Duckert F
    Thromb Haemost; 1985 Apr; 53(2):242-4. PubMed ID: 2410997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A direct role for C1 inhibitor in regulation of leukocyte adhesion.
    Cai S; Dole VS; Bergmeier W; Scafidi J; Feng H; Wagner DD; Davis AE
    J Immunol; 2005 May; 174(10):6462-6. PubMed ID: 15879149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.